Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCTR20230405005Phase 3Unknown
A Phase 3 trial of triamcinolone acetonide in end-stage kidney disease (ESKD), sponsored by Ramathibodi Hospital. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on TCTR20230405005.